Health Receipt of novel hormonal therapy for advanced prostate cancer varies with race Posted on January 1, 2024 by miyuru For Medicare recipients with innovative prostate cancer (PCa), invoice of unique hormone treatment (NHT) representatives differs with race, according to a research study released online Dec. 1 in JAMA Network….